Related Experiment Video
Updated: May 3, 2026

Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
An update on medication management of behavioral disorders in autism
Danielle A Baribeau1, Evdokia Anagnostou
1Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Abstract:
Autism spectrum disorder is often comorbid with behavioral disturbances such as irritability, aggression and hyperactivity. Throughout the mid 2000s, several large-scale controlled clinical trials were published leading to the approval of two medications (aripiprazole and risperidone) for treatment of irritability in this condition. This review serves as an update regarding new research findings regarding psychopharmacology for children and adolescents with ASD. In summary, the past five years have yielded no further approved medications with ASD as a primary indication. Important new research results include 1) long-term safety and efficacy data (52 week) regarding treatment with aripiprazole for irritability, 2) consensus regarding potential harm from SSRIs for treatment of repetitive behaviors in children/ adolescents with ASD, 3) a randomized controlled trial showing modest benefits from atomoxetine on hyperactivity, 4) many novel agents currently under investigation.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Drug Therapy
Antianxiety Medications
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Behavior Modification
A real-world application of operant conditioning principles is applied...
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Psychosis: Goals of Pharmacotherapy

